Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY.R


Primary Symbol: T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Comment by StewartCatsoon Dec 18, 2023 10:34am
113 Views
Post# 35789737

RE: $20.5-$25.5 is TD's fair value opinion

RE: $20.5-$25.5 is TD's fair value opinion

The Company has agreed to extend the previously announced exclusivity period granted to PCP to January 15, 2024 to complete negotiation of a definitive agreement for the Proposed Transaction and to allow PCP to finalize its equity financing arrangements for the Proposed Transaction.

The entering into of a definitive agreement concerning the Proposed Transaction remains subject to, among other things, as at the time the definitive agreement is entered into, (i) PCP having secured fully committed equity financing; (ii) the negotiation and execution of a definitive agreement for the Proposed Transaction on terms satisfactory to PCP and Neighbourly; (iii) receipt from TD Securities Inc. ("TD"), financial advisor and independent valuator to the committee of independent directors (the "Transaction Committee") formed by the Board of Directors of the Company (the "Board"), of an updated formal valuation of the Common Shares initially orally delivered by TD to the Transaction Committee on October 2, 2023 (the "Formal Valuation"); and (iv) receipt from TD of an updated fairness opinion initially orally delivered by TD to the Transaction Committee on October 2, 2023 (the "Fairness Opinion"), containing a fairness conclusion consistent with the Fairness Opinion.

We are still awaiting the final evaluation.
<< Previous
Bullboard Posts
Next >>